← Back to headlines
Merck's Investment Boosts Funding for Vaginal Drug Delivery Research
Merck has significantly impacted the funding landscape for vaginal drug delivery, addressing a previous lack of investment in the area.
20 Apr, 11:00 — 20 Apr, 11:00
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
3h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
4h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
7h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
13h ago